首頁 > 市場調查報告書 > 製藥

婦科治療

市場調查報告書

商品編碼

1406669

女性健康市場 - 2018-2028 年全球產業規模、佔有率、趨勢、機會和預測，按藥物、按應用、地區和競爭細分

Women's Health Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Drugs, By Application, By Region and Competition

出版日期: 2023年11月07日 | 出版商:

TechSci Research | 英文 190 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2022 年，全球女性健康市場價值為 140.8 億美元，預計在預測期內將出現令人印象深刻的成長，到 2028 年CAGR為6.45%。女性健康市場涵蓋廣泛的醫療、診斷和治療解決方案，旨在滿足女性在不同生命階段獨特的醫療保健需求。這個市場是動態的、多方面的，反映了女性健康的各種狀況和關注。

女性健康市場由多種因素驅動，包括人們對女性健康問題的認知和宣傳的提高、醫療技術的進步以及對預防保健的日益關注。該市場的特點是對針對女性特定生物和生理需求的個人化和全面的醫療保健解決方案的需求不斷成長。市場分為幾個關鍵領域，每個領域都針對女性健康的不同面向。生殖健康，包括生育治療、避孕藥和產前護理，是重要的部分。婦科健康，包括多囊性卵巢症候群 (PCOS)、子宮內膜異位症和子宮肌瘤等疾病的診斷和治療，是另一個關鍵領域。乳房健康，重點是乳癌篩檢、診斷和治療，是女性健康市場的一個突出方面。骨質疏鬆症和骨骼健康、更年期健康和性健康是另外的專業部分，展示了女性保健的綜合性。

技術創新在塑造女性健康市場方面發揮關鍵作用。 3D 乳房 X 光攝影和乳房 MRI 等先進影像技術可增強乳癌的早期發現。婦科手術的微創手術技術可縮短恢復時間並改善患者的治療效果。遠距醫療和數位醫療解決方案正在成為遠距諮詢、監控和病患教育不可或缺的一部分。

市場概況
預測期	2024-2028
2022 年市場規模	140.8億美元
2028 年市場規模	203.1億美元
2023-2028 年CAGR	6.45%
成長最快的細分市場	女性不孕症
最大的市場	北美洲

該市場還解決懷孕和孕產婦健康問題，提供一系列產前護理、孕產診斷和分娩解決方案。胎兒監測技術、非侵入性產前檢測 (NIPT) 和母胎醫學創新有助於改善母親和嬰兒的結果。女性健康市場越來越重視預防保健和健康。常規篩檢、疫苗接種和生活方式干涉是女性醫療保健計劃的重要組成部分。考慮心理健康、營養和整體福祉的整體方法正在獲得關注。

市場規模及預測
- 按價值
市佔率及預測
- 按藥物（Prolia、Xgeva、Evista、Mirena、Zometa 等）
- 按應用（女性不孕症、停經後骨質疏鬆症、子宮內膜異位症、避孕、其他）
- 按地區
- 按公司分類 (2022)
市場地圖
- 按藥物分類
- 按應用
- 按地區

第 5 章：亞太地區女性健康市場展望

市場規模及預測
- 按價值
市佔率及預測
- 按藥物分類
- 按應用
- 按國家/地區
亞太地區：國家分析
- 中國女性健康
- 印度女性健康
- 澳洲女性健康
- 日本女性健康
- 韓國女性健康

第 6 章：歐洲女性健康市場展望

市場規模及預測
- 按價值
市佔率及預測
- 按藥物分類
- 按應用
- 按國家/地區
歐洲：國家分析
- 法國
- 德國
- 西班牙
- 義大利
- 英國

第 7 章：北美女性健康市場展望

市場規模及預測
- 按價值
市佔率及預測
- 按藥物分類
- 按應用
- 按國家/地區
北美：國家分析
- 美國
- 墨西哥
- 加拿大

第 8 章：南美洲女性健康市場展望

市場規模及預測
- 按價值
市佔率及預測
- 按藥物分類
- 按應用
- 按國家/地區
南美洲：國家分析
- 巴西
- 阿根廷
- 哥倫比亞

第 9 章：中東與非洲女性健康市場展望

市場規模及預測
- 按價值
市佔率及預測
- 按藥物分類
- 按應用
- 按國家/地區
MEA：國家分析
- 南非婦女健康
- 沙烏地阿拉伯婦女健康
- 阿拉伯聯合大公國婦女健康
- 埃及婦女健康

第 10 章：市場動態

促進要素
挑戰

第 11 章：市場趨勢與發展

最近的發展
應用程式啟動
併購

第 12 章：全球女性健康市場：SWOT 分析

第 13 章：波特的五力分析

產業競爭
新進入者的潛力
供應商的力量
客戶的力量
替代申請的威脅

第14章：競爭格局

艾伯維公司
拜耳公司
默克公司
輝瑞公司
梯瓦製藥工業股份有限公司
安進公司
阿波西克斯製藥公司
布萊雷克斯實驗室公司
輝凌有限公司
敏捷療法

第 15 章：策略建議

第 16 章：關於我們與免責聲明

簡介目錄

Product Code: 19868

Global Women's Health Market has valued at USD 14.08 Billion in 2022 and is anticipated to project impressive growth in the forecast period with a CAGR of 6.45% through 2028. The Women's Health Market encompasses a broad spectrum of medical, diagnostic, and therapeutic solutions designed to address the unique healthcare needs of women across different life stages. This market is dynamic and multifaceted, reflecting the diverse range of conditions and concerns specific to women's health.

The Women's Health Market is driven by various factors, including increasing awareness and advocacy for women's health issues, advancements in medical technologies, and a growing focus on preventive care. The market is characterized by a rising demand for personalized and comprehensive healthcare solutions tailored to women's specific biological and physiological needs. The market is segmented into several key areas, each addressing distinct aspects of women's health. Reproductive health, encompassing fertility treatments, contraceptives, and prenatal care, is a significant segment. Gynecological health, including diagnostics and treatments for conditions like polycystic ovary syndrome (PCOS), endometriosis, and uterine fibroids, is another critical area. Breast health, with a focus on breast cancer screening, diagnostics, and treatment, is a prominent aspect of the Women's Health Market. Osteoporosis and bone health, menopausal health, and sexual health are additional specialized segments, showcasing the comprehensive nature of women's healthcare.

Technological innovations play a pivotal role in shaping the Women's Health Market. Advanced imaging technologies, such as 3D mammography and breast MRI, enhance early detection of breast cancer. Minimally invasive surgical techniques for gynecological procedures reduce recovery times and improve patient outcomes. Telehealth and digital health solutions are becoming integral for remote consultations, monitoring, and patient education.

Market Overview
Forecast Period	2024-2028
Market Size 2022	USD 14.08 Billion
Market Size 2028	USD 20.31 Billion
CAGR 2023-2028	6.45%
Fastest Growing Segment	Female Infertility
Largest Market	North America

The market also addresses pregnancy and maternal health, offering a range of prenatal care, maternity diagnostics, and birthing solutions. Fetal monitoring technologies, non-invasive prenatal testing (NIPT), and innovations in maternal-fetal medicine contribute to improved outcomes for both mothers and infants. Preventive care and wellness are increasingly emphasized in the Women's Health Market. Routine screenings, vaccinations, and lifestyle interventions are essential components of women's healthcare plans. Holistic approaches that consider mental health, nutrition, and overall well-being are gaining traction.

Challenges in the Women's Health Market include disparities in access to healthcare, stigma around certain conditions, and the need for continued research in areas like gynecological cancers and reproductive health. However, these challenges present opportunities for innovation, advocacy, and the development of targeted solutions to address unmet needs in women's healthcare.

The Women's Health Market is a global phenomenon, with key players operating internationally. North America, particularly the United States, dominates the market due to its advanced healthcare infrastructure, high awareness levels, and significant investments in research and development. Europe follows closely, with a strong emphasis on women's health in healthcare policies. The Asia-Pacific region, with its large and diverse population, represents a burgeoning market, driven by increasing healthcare awareness and rising disposable incomes.

The future of the Women's Health Market is poised for continued growth and evolution. Advancements in precision medicine, genomics, and personalized therapies hold promise for more targeted and effective treatments. Increased collaboration between healthcare providers, researchers, and industry stakeholders is expected to drive innovation. As societal awareness of women's health issues grows, there is a heightened focus on addressing unmet needs, reducing disparities, and fostering a comprehensive and patient-centric approach to women's healthcare. The Women's Health Market is not only a critical component of the broader healthcare landscape but also a dynamic and vital sector dedicated to enhancing and preserving the well-being of women worldwide.

Key Market Drivers

Preventive Healthcare Emphasis

Preventive healthcare emphasis is a driving force behind the growth of the Women's Health Market, signifying a paradigm shift towards proactive wellness strategies. This emphasis reflects a recognition that preventive measures are crucial for maintaining and improving women's overall health. Regular screenings, vaccinations, and lifestyle interventions are becoming integral components of women's healthcare, aiming to detect and address potential health issues at their early stages. Routine screenings, including mammograms, Pap smears, and bone density tests, empower women to take charge of their health by identifying conditions such as breast cancer, cervical abnormalities, and osteoporosis in their nascent phases. These early interventions enhance treatment efficacy and contribute to improved health outcomes. In the realm of women's health, preventive care extends beyond traditional screenings. Lifestyle interventions, such as promoting healthy diets, exercise, and mental health awareness, are gaining prominence. Addressing risk factors associated with chronic conditions, like heart disease and diabetes, is integral to preventive healthcare strategies.

The emphasis on preventive healthcare is not only beneficial for individual well-being but also has broader societal implications. By proactively addressing health concerns, there is a potential to reduce the burden on healthcare systems, decrease healthcare costs, and enhance overall public health. Technology plays a pivotal role in facilitating preventive healthcare in women's health. Digital health platforms, wearable devices, and telehealth services provide women with tools and resources to monitor and manage their health proactively. These technologies contribute to a more engaged and empowered healthcare approach, enabling women to make informed decisions about their well-being. The growing awareness and emphasis on preventive healthcare in the Women's Health Market reflect a holistic understanding of women's health needs. It signifies a departure from a reactive model of healthcare to a proactive and personalized approach that aligns with the goal of promoting longevity, vitality, and overall quality of life for women across diverse age groups and backgrounds. As this emphasis continues to shape healthcare practices, the Women's Health Market is poised for sustained growth and innovation in preventive care solutions.

Women's Empowerment and Education

Women's empowerment and education are powerful drivers propelling the Women's Health Market towards transformative growth. As women globally gain increased access to education and opportunities, they become more proactive in managing their health, leading to a surge in demand for specialized healthcare services. Education plays a pivotal role in informing women about their unique health needs, preventive measures, and available healthcare options. Empowered and educated women are more likely to prioritize their health, engage in routine screenings, and make informed decisions about their well-being. This heightened awareness creates a positive feedback loop, where women actively seek out healthcare services tailored to their specific requirements. Moreover, as women take on more prominent roles in society, their influence extends to healthcare decisions for themselves and their families. Empowered women advocate for comprehensive healthcare solutions that address not only reproductive health but also broader aspects of well-being, including mental health, nutrition, and lifestyle choices.

The increasing emphasis on preventive healthcare and wellness aligns with the empowerment narrative. Educated women understand the importance of proactive health measures, leading to a growing demand for preventive screenings, vaccinations, and lifestyle interventions. This shift from a reactive to a proactive healthcare approach is reshaping the landscape of women's health. Women's empowerment is also evident in their engagement with digital health platforms, where technology facilitates access to health information, monitoring tools, and telehealth services. This tech-savvy approach empowers women to take control of their health journey, contributing to a more informed and participatory healthcare experience.

In summary, women's empowerment and education are catalyzing forces behind the growth of the Women's Health Market. As women become increasingly empowered to make informed decisions about their health, the market responds with innovative solutions, personalized care options, and a more comprehensive approach to women's healthcare needs. This dynamic interplay between empowerment, education, and healthcare is not only reshaping the industry but also fostering a culture of proactive well-being among women worldwide.

Key Market Challenges

Healthcare Disparities

Healthcare disparities pose a significant challenge for the Women's Health Market, creating inequalities in access to crucial services. Socioeconomic factors, geographical location, and cultural barriers contribute to uneven healthcare access, impacting the delivery of essential women's health services. Addressing these disparities is essential for ensuring that all women, regardless of background or circumstance, have equal access to preventive screenings, reproductive healthcare, and treatments. Overcoming these challenges requires targeted interventions, community engagement, and policy measures to bridge the gaps and promote equitable healthcare access for women across diverse demographics.

Stigma and Societal Taboos

Stigma and societal taboos present a formidable challenge for the Women's Health Market by impeding open discussions and proactive healthcare-seeking behaviors. Certain women's health issues, including reproductive health, mental health, and sexual health, are often surrounded by cultural stigmas and taboos, discouraging women from seeking timely medical attention. Overcoming these challenges requires concerted efforts to destigmatize these issues, foster awareness, and create a supportive environment that encourages women to prioritize their health. Addressing stigma is vital for ensuring comprehensive care and promoting women's well-being across diverse cultural contexts.

Research Gaps and Underrepresentation

Research gaps and underrepresentation in clinical trials pose a significant challenge for the Women's Health Market. Historically, women have been underrepresented in medical research, leading to gaps in understanding gender-specific health conditions and responses to treatments. This underrepresentation hinders the development of tailored and effective healthcare solutions for women. Bridging these gaps requires a concerted effort to actively involve women in research, address biases, and ensure that clinical trials are designed to account for gender differences. Closing these research gaps is essential for advancing evidence-based women's healthcare and providing more personalized and effective medical interventions.

Mental Health Stigmatization

Mental health stigmatization poses a significant challenge for the Women's Health Market, hindering timely diagnosis and treatment. Societal stigma surrounding mental health issues can discourage women from seeking help, exacerbating mental health disparities. Overcoming this challenge requires destigmatizing mental health, fostering open conversations, and integrating mental health considerations into overall women's healthcare. Addressing mental health stigmatization is vital for promoting holistic well-being and ensuring that women receive the necessary support and resources for mental health conditions. It requires a collective effort to reshape societal perceptions and create an environment where seeking mental health care is normalized and encouraged.

Key Market Trends

Digital Health Integration

Digital health integration is a prominent trend in the Women's Health Market, revolutionizing how healthcare is accessed and managed. The adoption of telehealth, mobile apps, and wearable devices empowers women to actively participate in their health journeys. Telehealth facilitates remote consultations, enhancing accessibility to specialized care. Mobile apps provide tools for menstrual tracking, pregnancy monitoring, and mental health support. Wearable devices offer real-time health data, promoting preventive measures. This trend not only fosters a more patient-centric approach but also enables personalized health insights, contributing to a proactive and empowered women's healthcare experience. Digital health integration is pivotal in advancing the efficiency and effectiveness of women's health services.

Personalized Medicine

Personalized medicine is a significant trend in the Women's Health Market, tailoring healthcare interventions based on individual characteristics. This approach considers genetic, hormonal, and lifestyle factors to provide precise and targeted treatments. In areas like reproductive health and breast cancer, personalized medicine enhances diagnostic accuracy and treatment efficacy. Genetic testing allows for proactive measures, such as fertility planning and identifying hereditary risks. The trend towards personalized medicine reflects a paradigm shift, acknowledging the uniqueness of each woman's biology and health profile, ultimately improving healthcare outcomes and contributing to the advancement of more individualized and effective women's health solutions.

Fertility Technology Advancements

Fertility technology advancements are a key trend in the Women's Health Market, reshaping the landscape of reproductive health. Innovations in in vitro fertilization (IVF), preimplantation genetic testing (PGT), and egg freezing offer unprecedented possibilities for family planning. These technologies provide solutions to infertility challenges, enabling women to make informed choices about their reproductive futures. The trend towards fertility technology advancements reflects a growing societal awareness and acceptance of diverse family-building options. It empowers women to take control of their reproductive health, contributing to more inclusive and comprehensive women's healthcare services that address the evolving needs and aspirations of individuals and families.

Mental Health Focus

A growing trend in the Women's Health Market is an increased focus on mental health. Recognizing the integral connection between mental and physical well-being, healthcare providers are prioritizing mental health services for women. This trend addresses conditions such as postpartum depression, anxiety, and other mental health disorders. Integrated approaches that combine mental health support with routine women's healthcare are gaining prominence, fostering a holistic approach to well-being. By acknowledging and addressing mental health needs, the Women's Health Market is aligning with broader societal awareness, contributing to more comprehensive and patient-centric healthcare services for women across diverse life stages.

Segmental Insights

Drugs Insights

Based on the Drugs, Prolia, a medication primarily used to treat osteoporosis in postmenopausal women, has gained dominance in the Women's Health Market due to its efficacy in reducing fracture risks and increasing bone density. As a monoclonal antibody, Prolia targets specific cells involved in bone breakdown, offering a targeted and effective solution for managing osteoporosis, a prevalent condition in postmenopausal women. Its ability to address a significant health concern in this demographic, coupled with extensive clinical research supporting its safety and effectiveness, positions Prolia as a prominent and trusted choice, contributing to its dominance in the Women's Health Market.

Application Insights

Female infertility is a dominant focus in the Women's Health Market due to its profound impact on reproductive well-being. As societal trends lean towards delayed childbearing, the prevalence of fertility issues rises. The market addresses this by offering a spectrum of solutions ranging from assisted reproductive technologies like in vitro fertilization (IVF) to hormonal treatments. Advanced diagnostics and personalized interventions contribute to the dominance of female infertility in the Women's Health Market, emphasizing the market's commitment to providing comprehensive and effective solutions for women facing challenges in conceiving and realizing their reproductive goals.

Regional Insights

North America's dominance in the Women's Health market is attributed to advanced healthcare infrastructure, high prevalence of chronic kidney diseases, and favorable reimbursement policies. The region's robust economic landscape facilitates widespread access to costly dialysis treatments. Moreover, a well-established regulatory framework ensures quality standards. Investments in technological advancements and a growing aging population further drive market growth. The presence of key market players and extensive research activities contribute to North America's leadership in providing advanced renal replacement therapies, solidifying its position as a pivotal hub for Women's Health market dominance.

Key Market Players

AbbVie, Inc

Bayer AG

Merck & Co., Inc

Pfizer, Inc

Teva Pharmaceutical Industries Ltd

Amgen, Inc

Apothecus Pharmaceutical Corp

Blairex Laboratories, Inc

Ferring B.V.

Agile Therapeutics

Report Scope:

In this report, the Global Women's Health Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Women's Health Market, By Drugs:

Prolia
Xgeva
Evista
Mirena
Zometa
Others

Women's Health Market, By Application:

Female Infertility
Post enopausal Osteoporosis
Endometriosis
Contraception
Others

Women's Health Market, By Region:

North America
United States
Canada
Mexico
Europe
France
United Kingdom
Italy
Germany
Spain
Asia-Pacific
China
India
Japan
Australia
South Korea
South America
Brazil
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Women's Health Market.

Available Customizations:

Global Women's Health market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

1. Product Overview

1.1. Market Definition
1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. Global Women's Health Market Outlook

4.1. Market Size & Forecast
- 4.1.1. By Value
4.2. Market Share & Forecast
- 4.2.1. By Drugs (Prolia, Xgeva, Evista, Mirena, Zometa, Others)
- 4.2.2. By Application (Female Infertility, Post enopausal Osteoporosis, Endometriosis, Contraception, Others)
- 4.2.3. By Region
- 4.2.4. By Company (2022)
4.3. Market Map
- 4.3.1. By Drugs
- 4.3.2. By Application
- 4.3.3. By Region

5. Asia Pacific Women's Health Market Outlook

5.1. Market Size & Forecast
- 5.1.1. By Value
5.2. Market Share & Forecast
- 5.2.1. By Drugs
- 5.2.2. By Application
- 5.2.3. By Country
5.3. Asia Pacific: Country Analysis
- 5.3.1. China Women's Health Market Outlook
  - 5.3.1.1. Market Size & Forecast
    - 5.3.1.1.1. By Value
  - 5.3.1.2. Market Share & Forecast
    - 5.3.1.2.1. By Drugs
    - 5.3.1.2.2. By Application
- 5.3.2. India Women's Health Market Outlook
  - 5.3.2.1. Market Size & Forecast
    - 5.3.2.1.1. By Value
  - 5.3.2.2. Market Share & Forecast
    - 5.3.2.2.1. By Drugs
    - 5.3.2.2.2. By Application
- 5.3.3. Australia Women's Health Market Outlook
  - 5.3.3.1. Market Size & Forecast
    - 5.3.3.1.1. By Value
  - 5.3.3.2. Market Share & Forecast
    - 5.3.3.2.1. By Drugs
    - 5.3.3.2.2. By Application
- 5.3.4. Japan Women's Health Market Outlook
  - 5.3.4.1. Market Size & Forecast
    - 5.3.4.1.1. By Value
  - 5.3.4.2. Market Share & Forecast
    - 5.3.4.2.1. By Drugs
    - 5.3.4.2.2. By Application
- 5.3.5. South Korea Women's Health Market Outlook
  - 5.3.5.1. Market Size & Forecast
    - 5.3.5.1.1. By Value
  - 5.3.5.2. Market Share & Forecast
    - 5.3.5.2.1. By Drugs
    - 5.3.5.2.2. By Application

6. Europe Women's Health Market Outlook

6.1. Market Size & Forecast
- 6.1.1. By Value
6.2. Market Share & Forecast
- 6.2.1. By Drugs
- 6.2.2. By Application
- 6.2.3. By Country
6.3. Europe: Country Analysis
- 6.3.1. France Women's Health Market Outlook
  - 6.3.1.1. Market Size & Forecast
    - 6.3.1.1.1. By Value
  - 6.3.1.2. Market Share & Forecast
    - 6.3.1.2.1. By Drugs
    - 6.3.1.2.2. By Application
- 6.3.2. Germany Women's Health Market Outlook
  - 6.3.2.1. Market Size & Forecast
    - 6.3.2.1.1. By Value
  - 6.3.2.2. Market Share & Forecast
    - 6.3.2.2.1. By Drugs
    - 6.3.2.2.2. By Application
- 6.3.3. Spain Women's Health Market Outlook
  - 6.3.3.1. Market Size & Forecast
    - 6.3.3.1.1. By Value
  - 6.3.3.2. Market Share & Forecast
    - 6.3.3.2.1. By Drugs
    - 6.3.3.2.2. By Application
- 6.3.4. Italy Women's Health Market Outlook
  - 6.3.4.1. Market Size & Forecast
    - 6.3.4.1.1. By Value
  - 6.3.4.2. Market Share & Forecast
    - 6.3.4.2.1. By Drugs
    - 6.3.4.2.2. By Application
- 6.3.5. United Kingdom Women's Health Market Outlook
  - 6.3.5.1. Market Size & Forecast
    - 6.3.5.1.1. By Value
  - 6.3.5.2. Market Share & Forecast
    - 6.3.5.2.1. By Drugs
    - 6.3.5.2.2. By Application

7. North America Women's Health Market Outlook

7.1. Market Size & Forecast
- 7.1.1. By Value
7.2. Market Share & Forecast
- 7.2.1. By Drugs
- 7.2.2. By Application
- 7.2.3. By Country
7.3. North America: Country Analysis
- 7.3.1. United States Women's Health Market Outlook
  - 7.3.1.1. Market Size & Forecast
    - 7.3.1.1.1. By Value
  - 7.3.1.2. Market Share & Forecast
    - 7.3.1.2.1. By Drugs
    - 7.3.1.2.2. By Application
- 7.3.2. Mexico Women's Health Market Outlook
  - 7.3.2.1. Market Size & Forecast
    - 7.3.2.1.1. By Value
  - 7.3.2.2. Market Share & Forecast
    - 7.3.2.2.1. By Drugs
    - 7.3.2.2.2. By Application
- 7.3.3. Canada Women's Health Market Outlook
  - 7.3.3.1. Market Size & Forecast
    - 7.3.3.1.1. By Value
  - 7.3.3.2. Market Share & Forecast
    - 7.3.3.2.1. By Drugs
    - 7.3.3.2.2. By Application

8. South America Women's Health Market Outlook

8.1. Market Size & Forecast
- 8.1.1. By Value
8.2. Market Share & Forecast
- 8.2.1. By Drugs
- 8.2.2. By Application
- 8.2.3. By Country
8.3. South America: Country Analysis
- 8.3.1. Brazil Women's Health Market Outlook
  - 8.3.1.1. Market Size & Forecast
    - 8.3.1.1.1. By Value
  - 8.3.1.2. Market Share & Forecast
    - 8.3.1.2.1. By Drugs
    - 8.3.1.2.2. By Application
- 8.3.2. Argentina Women's Health Market Outlook
  - 8.3.2.1. Market Size & Forecast
    - 8.3.2.1.1. By Value
  - 8.3.2.2. Market Share & Forecast
    - 8.3.2.2.1. By Drugs
    - 8.3.2.2.2. By Application
- 8.3.3. Colombia Women's Health Market Outlook
  - 8.3.3.1. Market Size & Forecast
    - 8.3.3.1.1. By Value
  - 8.3.3.2. Market Share & Forecast
    - 8.3.3.2.1. By Drugs
    - 8.3.3.2.2. By Application

9. Middle East and Africa Women's Health Market Outlook

9.1. Market Size & Forecast
- 9.1.1. By Value
9.2. Market Share & Forecast
- 9.2.1. By Drugs
- 9.2.2. By Application
- 9.2.3. By Country
9.3. MEA: Country Analysis
- 9.3.1. South Africa Women's Health Market Outlook
  - 9.3.1.1. Market Size & Forecast
    - 9.3.1.1.1. By Value
  - 9.3.1.2. Market Share & Forecast
    - 9.3.1.2.1. By Drugs
    - 9.3.1.2.2. By Application
- 9.3.2. Saudi Arabia Women's Health Market Outlook
  - 9.3.2.1. Market Size & Forecast
    - 9.3.2.1.1. By Value
  - 9.3.2.2. Market Share & Forecast
    - 9.3.2.2.1. By Drugs
    - 9.3.2.2.2. By Application
- 9.3.3. UAE Women's Health Market Outlook
  - 9.3.3.1. Market Size & Forecast
    - 9.3.3.1.1. By Value
  - 9.3.3.2. Market Share & Forecast
    - 9.3.3.2.1. By Drugs
    - 9.3.3.2.2. By Application
- 9.3.4. Egypt Women's Health Market Outlook
  - 9.3.4.1. Market Size & Forecast
    - 9.3.4.1.1. By Value
  - 9.3.4.2. Market Share & Forecast
    - 9.3.4.2.1. By Drugs
    - 9.3.4.2.2. By Application